Status:
RECRUITING
NORDTREAT Prospective Study on Inflammatory Bowel Disease
Lead Sponsor:
University of Southern Denmark
Collaborating Sponsors:
Nordic Bioscience A/S
University Hospital Bispebjerg and Frederiksberg
Conditions:
Inflammatory Bowel Diseases (IBD)
Crohn Disease (CD)
Eligibility:
All Genders
18+ years
Brief Summary
Inflammatory bowel disease (IBD), primarily ulcerative colitis (UC) and Crohn's disease (CD), is a chronic disease entity affecting individuals of all ages, and which may severely impact the lives of ...
Detailed Description
The primary aim is to identify molecular markers (e.g. in the blood and stools) for discrimination between individuals diagnosed with inflammatory bowel disease (IBD) inclusive Crohn's disease (CD), u...
Eligibility Criteria
Inclusion
- To be included in the study, the participants must meet the following criteria:
- Referred on the suspicion of inflammatory bowel disease
- Adult (+18 years of age)
- Written informed consent to participate in the study
Exclusion
- A previous known diagnosis of Crohn's disease, ulcerative colitis or IBD-U
- Unable to provide informed consent
- Unable to comply with protocol requirements (e.g., for reasons including alcohol and/or recreational drug abuse)
Key Trial Info
Start Date :
February 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2031
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT05414578
Start Date
February 7 2022
End Date
January 1 2031
Last Update
June 10 2022
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Southern Denmark
Aabenraa, Denmark, 6200
2
SVS Esbjerg Hospital
Esbjerg, Denmark
3
Odense University Hospital
Odense, Denmark
4
OUH Svendborg Hospital
Svendborg, Denmark